| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.36B | +33.4% |
| Cost of Revenue | $4.65B | +35.2% |
| Gross Profit | $2.72B | +30.4% |
| R&D Expense | $232.0M | +12.6% |
| SG&A Expense | $1.76B | +43.2% |
| Operating Income | $652.0M | +4.8% |
| Interest Expense | $49.0M | -2.0% |
| Pre-tax Income | $635.0M | +44.3% |
| Income Tax | $26.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.02B | +7.9% |
| Accounts Receivable | $1.62B | +47.5% |
| Inventory | $1.02B | +27.4% |
| Current Assets | $3.88B | +29.0% |
| Total Assets | $16.11B | +102.6% |
| Current Liabilities | $2.21B | +38.7% |
| Long-term Debt | $2.27B | +20.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $837.0M | +40.4% |
| Investing Cash Flow | -$628.0M | -228.8% |
| Financing Cash Flow | -$157.0M | +80.1% |
| -69.4% |
| Net Income | $609.0M | +71.5% |
| EPS (Basic) | $2.81 | +42.6% |
| EPS (Diluted) | $2.79 | +42.3% |
| Total Liabilities |
| $5.94B |
| +33.4% |
| Stockholders' Equity | $10.17B | +191.0% |